Anacetrapib
≥99%
- Product Code: 77453
CAS:
875446-37-0
Molecular Weight: | 637.51 g./mol | Molecular Formula: | C₃₀H₂₅F₁₀NO₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C |
Product Description:
Anacetrapib is primarily investigated for its potential in cardiovascular disease management. It functions as a cholesteryl ester transfer protein (CETP) inhibitor, which helps in increasing high-density lipoprotein (HDL) cholesterol levels while reducing low-density lipoprotein (LDL) cholesterol. This dual action makes it a promising candidate for reducing the risk of heart attacks and strokes in patients with a history of cardiovascular issues. Clinical trials have explored its efficacy in combination with statins to further enhance cholesterol management. However, its development has faced challenges, including concerns about long-term safety and side effects, which have limited its widespread use. Research continues to evaluate its benefits and risks in specific patient populations.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | White to off-white solid |
PURITY | 98.5-100 |
Infrared spectrum | Conforms to Structure |
NMR | Conforms to Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿9,190.00 |
+
-
|
0.010 | 10-20 days | ฿15,960.00 |
+
-
|
0.050 | 10-20 days | ฿53,980.00 |
+
-
|
0.250 | 10-20 days | ฿98,800.00 |
+
-
|
Anacetrapib
Anacetrapib is primarily investigated for its potential in cardiovascular disease management. It functions as a cholesteryl ester transfer protein (CETP) inhibitor, which helps in increasing high-density lipoprotein (HDL) cholesterol levels while reducing low-density lipoprotein (LDL) cholesterol. This dual action makes it a promising candidate for reducing the risk of heart attacks and strokes in patients with a history of cardiovascular issues. Clinical trials have explored its efficacy in combination with statins to further enhance cholesterol management. However, its development has faced challenges, including concerns about long-term safety and side effects, which have limited its widespread use. Research continues to evaluate its benefits and risks in specific patient populations.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :